Greg Guilcher

Associate Professor

Cumming School of Medicine

BSc, MD, FRCPC, FAAP


Contact information

Phone

Office: 403-955-7476

Web presence

PubMed


Preferred method of communication

ADMIN ASSISTANT

Amanda Wagner

Email: amanda.wagner@ahs.ca

Office: 403-955-7272


Research and teaching

Research areas

  • Bone marrow transplantation for sickle cell disease
  • acute and late effects of cancer therapy
  • HC

Summary of Research

Research interests include acute and late toxicities of BMT, as well as the study of novel low-toxicity approaches to transplant for pediatric non-malignant diseases. Greg is interested in studying graft survival post BMT, novel methods of evaluation chimerisms, family BMT decision-making, and neuropsychological outcomes. He also has an interest in pediatric BMT donor safety. A career goal is to expand access to BMT for sickle cell disease to low and middle income countries.Greg is a site investigator for numerous phase I, II and III clinical trials.


Biography

Co-Lead of the Alberta Children’s Hospital Hematopoietic Cell Transplant Long-Term Survivor Program, Chair Mentee of the Children’s Oncology Group HCT/Dermatology/Immunology Late Effects Taskforce, Vice Chair of the Board of Directors of the Sickle Transplant Alliance for Research, Vice-Chair of the Royal College Pediatric Hematology/Oncology Examination Committee, Program Director for Pediatric Hematology/Oncology at the University of Calgary.